Viewing Study NCT04239469


Ignite Creation Date: 2025-12-24 @ 10:57 PM
Ignite Modification Date: 2025-12-25 @ 8:25 PM
Study NCT ID: NCT04239469
Status: UNKNOWN
Last Update Posted: 2020-01-27
First Post: 2020-01-05
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase II Clinical Trial, Use of KL16-012 in Women With Fibromyalgia Refractary to Conventional Treatment.
Sponsor: Knop Laboratorios
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module